BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Biotech catalysts in 2026-02

155 industry Phase 2/3 trial readout(s) and 42 FDA decision event(s). Readouts include completed (ACTUAL) and still-estimated primary completion dates in this month, any status.

← 2026-01 | 2026-03 →

FDA decision events

DateEventStatusCompanyDrugSource
2026-02-02FDA approvalapprovedGENERAL AIR SERVICE & SUPPLY COMPANYAIRApproved 2026-02-02: AIR (NDA221287 ORIG1)
2026-02-03FDA approvalapprovedAVYXA HOLDINGSVYKOURAApproved 2026-02-03: VYKOURA (NDA220406 ORIG1)
2026-02-07Complete response lettercomplete responseREGENXBIO, Inc. RGNXclemidsogene lanparvoveeCRL 2026-02-07: REGENXBIO, Inc. BL 125840 (clemidsogene lanparvovee, (1))
2026-02-10FDA approvalapprovedMERCK SHARP DOHME MRKKEYTRUDAApproved 2026-02-10: KEYTRUDA (BLA125514 SUPPL186)
2026-02-10FDA approvalapprovedMERCK SHARP DOHME MRKKEYTRUDA QLEXApproved 2026-02-10: KEYTRUDA QLEX (BLA761467 SUPPL2)
2026-02-12FDA approvalapprovedACROTECH BIOPHARMAADQUEYApproved 2026-02-12: ADQUEY (NDA219474 ORIG1)
2026-02-12FDA approvalapprovedNOVARTIS NVSLEQVIOApproved 2026-02-12: LEQVIO (NDA214012 SUPPL18)
2026-02-12FDA approvalapprovedNOVARTIS NVSLEQVIOApproved 2026-02-12: LEQVIO (NDA214012 SUPPL17)
2026-02-13Complete response lettercomplete responseDisc Medicine, Inc. IRONCRL 2026-02-13: Disc Medicine, Inc. NDA 220707
2026-02-13FDA approvalapprovedAOP HLTH USRAPIBLYKApproved 2026-02-13: RAPIBLYK (NDA217202 SUPPL1)
2026-02-13FDA approvalapprovedHQ SPCLT PHARMACEFAZOLIN SODIUMApproved 2026-02-13: CEFAZOLIN SODIUM (NDA211413 SUPPL3)
2026-02-13FDA approvalapprovedAVYXA HOLDINGSAVOPEFApproved 2026-02-13: AVOPEF (NDA220200 ORIG1)
2026-02-13FDA approvalapprovedJANSSEN BIOTECHRYBREVANT FASPROApproved 2026-02-13: RYBREVANT FASPRO (BLA761484 ORIG1)
2026-02-13FDA approvalapprovedHARMONY HRMYWAKIXApproved 2026-02-13: WAKIX (NDA211150 SUPPL6)
2026-02-17FDA approvalapprovedINDUSTRIAL WELDING SUPPLY CO OF HARVEY INCMEDICAL AIR USPApproved 2026-02-17: MEDICAL AIR, USP (NDA221337 ORIG1)
2026-02-19FDA approvalapprovedASTRAZENECA AZNCALQUENCEApproved 2026-02-19: CALQUENCE (NDA210259 SUPPL12)
2026-02-19FDA approvalapprovedABBVIE ABBVVENCLEXTAApproved 2026-02-19: VENCLEXTA (NDA208573 SUPPL31)
2026-02-19FDA approvalapprovedASTRAZENECA AZNCALQUENCEApproved 2026-02-19: CALQUENCE (NDA216387 SUPPL6)
2026-02-20FDA approvalapprovedGUERBETELUCIREMApproved 2026-02-20: ELUCIREM (NDA216986 SUPPL9)
2026-02-20FDA approvalapprovedAVYXA HOLDINGSFAVLYXAApproved 2026-02-20: FAVLYXA (NDA220201 ORIG1)
2026-02-20FDA approvalapprovedVANDA PHARMS INC VNDABYSANTIApproved 2026-02-20: BYSANTI (NDA220358 ORIG1)
2026-02-23FDA approvalapprovedIMMEDICA PHARMA ABLOARGYSApproved 2026-02-23: LOARGYS (BLA761211 ORIG1)
2026-02-23FDA approvalapprovedREGENERON PHARMACEUTICALS REGNDUPIXENTApproved 2026-02-23: DUPIXENT (BLA761055 SUPPL75)
2026-02-24FDA approvalapprovedARRAY BIOPHARMA INC ADBRAFTOVIApproved 2026-02-24: BRAFTOVI (NDA210496 SUPPL19)
2026-02-24FDA approvalapprovedARRAY BIOPHARMA INC ADBRAFTOVIApproved 2026-02-24: BRAFTOVI (NDA210496 SUPPL21)
2026-02-25FDA approvalapprovedCHIESIJUXTAPIDApproved 2026-02-25: JUXTAPID (NDA203858 SUPPL27)
2026-02-25FDA approvalapprovedETON ETONDESMODAApproved 2026-02-25: DESMODA (NDA219873 ORIG1)
2026-02-26Complete response lettercomplete responseAmphastar Pharmaceuticals, Inc. AMPHWe also acknowledge receipt of your amendment dated as SP which was not reviewed for this actionCRL 2026-02-26: Amphastar Pharmaceuticals, Inc. BLA 761403 (We also acknowledge receipt of your amendment dated as SP which was not reviewed for this action)
2026-02-26FDA approvalapprovedGENSCORIZAFILMApproved 2026-02-26: RIZAFILM (NDA205394 SUPPL5)
2026-02-26FDA approvalapprovedBOEHRINGER INGELHEIMHERNEXEOSApproved 2026-02-26: HERNEXEOS (NDA219042 SUPPL1)
2026-02-27Complete response lettercomplete responseFresenius Kabi USA, LLCCRL 2026-02-27: Fresenius Kabi USA, LLC NDA 215818
2026-02-27Complete response lettercomplete responseFerring Pharmaceuticals Inc.CRL 2026-02-27: Ferring Pharmaceuticals Inc. BLA 761253
2026-02-27Complete response lettercomplete responseChiesi Farmaceutici S.p.ACRL 2026-02-27: Chiesi Farmaceutici S.p.A
2026-02-27Complete response lettercomplete responseFresenius Kabi USA, LLCCRL 2026-02-27: Fresenius Kabi USA, LLC NDA 214610
2026-02-27FDA approvalapprovedNOVO NORDISK INC NVOSOGROYAApproved 2026-02-27: SOGROYA (BLA761156 SUPPL15)
2026-02-27FDA approvalapprovedNOVO NORDISK INC NVOSOGROYAApproved 2026-02-27: SOGROYA (BLA761156 SUPPL14)
2026-02-27FDA approvalapprovedNOVO NORDISK INC NVOSOGROYAApproved 2026-02-27: SOGROYA (BLA761156 SUPPL12)
2026-02-27FDA approvalapprovedJANSSEN PRODSPREZCOBIXApproved 2026-02-27: PREZCOBIX (NDA205395 SUPPL29)
2026-02-27FDA approvalapprovedJANSSEN PRODSPREZCOBIX PREZCOBIX PEDApproved 2026-02-27: PREZCOBIX; PREZCOBIX PED (NDA220092 ORIG1)
2026-02-27FDA approvalapprovedBIOMARIN PHARM BMRNPALYNZIQApproved 2026-02-27: PALYNZIQ (BLA761079 SUPPL31)
2026-02-27FDA approvalapprovedALMATICADULOXETINE HYDROCHLORIDEApproved 2026-02-27: DULOXETINE HYDROCHLORIDE (NDA219131 ORIG1)
2026-02-27FDA approvalapprovedASCENDIS ASNDYUVIWELApproved 2026-02-27: YUVIWEL (NDA219164 ORIG1)

Trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-02 est.P3Zensun Sci. & Tech. Co., Ltd.NCT03388593 Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.Chronic Heart Failureunknown1600
2026-02 est.P3Can-Fite BioPharma CANFNCT05201404 Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 CirrhosisHepatocellular Carcinoma; Cirrhosisrecruiting471
2026-02 est.P2Marinus PharmaceuticalsNCT05757544 Safety and Efficacy Study of IV Ganaxolone as Adjuvant Therapy for Established Status Epilepticus (ESE)Status Epilepticuswithdrawn
2026-02 est.P1/P2SignPath Pharma, Inc.NCT05768919 Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade GliomasGlioblastomarecruiting30
2026-02 est.P2Shanghai Henlius BiotechNCT05787613 A Clinical Study to Evaluate the Efficacy and Safety of HLX26 (Anti-LAG-3 Monoclonal Antibody Injection) Combined With Serplulimab and Chemotherapy in PreviouslNSCLC Stage IVactive not recruiting132
2026-02 est.P1/P2Beijing Tide Pharmaceutical Co., LtdNCT06169722 TDI01 Suspension in the Treatment of Chronic Graft-versus-host Disease (cGVHD))GVHD, Chronicactive not recruiting60
2026-02 est.P3CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.NCT06182592 A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid LeukemiaHigh-risk (Secondary) Acute Myeloid Leukemiaunknown120
2026-02 est.P1/P2Beijing Mabworks Biotech Co., Ltd.NCT06232096 A Study of MBS314 in Participants With Relapsed/Refractory Multiple Myeloma.Relapsed or Refractory Multiple Myelomarecruiting154
2026-02 est.P1/P2Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT06237413 A Study of ZG2001 in Participants With KRAS Mutated Advanced Solid TumoursSolid Tumor; KRAS Mutation-Related Tumorsunknown110
2026-02 est.P2HRYZ Biotech Co.NCT06277154 MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue SarcomaLeiomyosarcoma; Liposarcoma; Synovial Sarcoma; Angiosarcoma; Undifferentiated Pleomorphic Sarcoma; Erecruiting148
2026-02 est.P2Lallemand Health SolutionsNCT06385054 Effect of Probiotics on Infantile Colic SymptomsInfantile Colicrecruiting70
2026-02 est.P3Jiangsu HengRui Medicine Co., Ltd.NCT06430437 A Study of SHR-A1811 in First-line Treatment of Patients With Advanced or Metastatic Non-small Cell Lung Cancer With HER2 MutationsNon-Small Cell Lung Cancer With HER2- Mutationsrecruiting300
2026-02 est.P2Alto Neuroscience ANRONCT06502964 Study of ALTO-101 in Patients With SchizophreniaSchizophrenia; Cognitive Impairmentrecruiting82
2026-02 est.P3Hasten Biopharmaceutical Co., Ltd.NCT06568471 A Study on Efficacy and Safety of HST101 in Chinese Patients with HypercholesterolemiaHypercholesterolemia; Dyslipidemias; Primary Hypercholesterolemia; Heterozygous Familial Hypercholesrecruiting210
2026-02 est.P2EnnovaBioNCT06632613 Efficacy and Safety of ENN0403 in Patients At High Risk for Acute Kidney Injury Following Elective Cardiac SurgeryCardiac Surgery Associated - Acute Kidney Injuryunknown200
2026-02 est.P2BiocadNCT06668792 An Open-Label Clinical Study of the Efficacy and Safety of BCD-248 in Patients With Relapsed/Refractory Multiple MyelomaRelapsed/Refractory Multiple Myelomarecruiting100
2026-02 est.P2/P3Veradermics, Inc. MANENCT06724614 Efficacy and Safety of VDPHL01 in Males With AGAAndrogenetic Alopecia; AGA; Male Pattern Baldnessactive not recruiting480
2026-02 est.P3Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.NCT06766357 A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye DiseaseModerate to Severe Dry Eyerecruiting360
2026-02 est.P2Jiangsu HengRui Medicine Co., Ltd.NCT07018453 A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic DrugsType 2 Diabetes Mellitusactive not recruiting173
2026-02 est.P2Jiangsu HengRui Medicine Co., Ltd.NCT07051486 A Phase II Trial of SHR-A1811 in HER2-Expressing Recurrent/Metastatic Cervical CancerRecurrent or Metastatic Cervical Cancerrecruiting60
2026-02 est.P2Jiangsu HengRui Medicine Co., Ltd.NCT07102888 A Clinical Study to Evaluate the Safety and Pharmacokinetics of Topical RSS0393 Ointment in Children and Adolescents With Plaque PsoriasisPlaque Psoriasis in Children; Plaque Psoriasis in Adolescentsnot yet recruiting20
2026-02 est.P2Telios Pharma, Inc.NCT07220408 Evaluation of TL-925 for the Treatment of Seasonal Allergic ConjunctivitisAllergic Conjunctivitisrecruiting60
2026-02 est.P1/P2WandercraftNCT07220733 Safety and Feasibility of a Self-Balancing Exoskeleton for Rehabilitation in the Thoracic Surgical Intensive Care Unit: a Pilot TrialCritical Illness; Post Operative Complication; Thoracic Surgeryrecruiting5
2026-02 est.P2Propedix, Inc.NCT07245667 Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional StudyTinea Pedisrecruiting150
2026-02 est.P2Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.NCT07311369 Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Pain Management in Abdominal SurgeryModerate to Severe Acute Postoperative Painrecruiting40
2026-02 est.P2Eirion Therapeutics Inc.NCT07321834 A Study to Evaluate AI-09 In Participants With Glabellar LinesGlabellar Linesactive not recruiting68
2026-02 est.P2Anhui Palo Alto Pharmaceuticals, Inc.NCT07326995 Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial AsthmaBronchial Asthmarecruiting60
2026-02-01P3Tasly Pharmaceutical Group Co., LtdNCT06068465 A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease PsychosisParkinson's Disease Psychosiscompleted248
2026-02-01 est.P2MedRegen LLCNCT06308926 MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS PatientsAcute Respiratory Distress Syndrome; Respiratory Failure; Respiratory Distress Syndrome; Respiratoryunknown60
2026-02-01 est.P1/P2Chengdu Zenitar Biomedical Technology Co., LtdNCT06484829 Purinostat Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple MyelomaRelapsed or Refractory Multiple Myeloma (RRMM)recruiting144
2026-02-01P2Regeneron Pharmaceuticals REGNNCT06608901 A Study of REGN7544 for the Treatment in Adult Patients With Sepsis-Induced HypotensionSepsis-Induced Hypotensioncompleted76
2026-02-01P2Aurigene Discovery Technologies LimitedNCT06760702 A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Colorectal, Ovarian, and Renal CancersOvarian Cancer; Colorectal Cancer; Renal Cancerterminated29
2026-02-01P3Shenyang Sunshine Pharmaceutical Co., LTD.NCT06980272 SSGJ-707 in Advanced Non-Small Cell Lung CancerAdvanced Non-Small Cell Lung Cancerterminated3
2026-02-02P3Merck Sharp & Dohme LLC MRKNCT04586231 A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)Carcinoma, Renal Cellactive not recruiting747
2026-02-02P3United Therapeutics UTHRNCT04708782 Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosis; Interstitial Lung Diseasecompleted598
2026-02-02P2Pfizer PFENCT05926960 A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced MelanomaMelanomaterminated38
2026-02-02P1/P2Synartro ABNCT06989645 A Phase 1/2a Study to Evaluate Single Intraarticular Injections of 3 Dose Levels of SYN321 and Placebo in Patients With Symptomatic Knee OsteoarthritisOsteoarthritis of Kneecompleted35
2026-02-03P2Seagen, a wholly owned subsidiary of PfizerNCT04609566 Brentuximab Vedotin With Pembrolizumab in Metastatic Solid TumorsMelanoma; Non-small Cell Lung Cancer; Squamous Cell Carcinoma of the Head and Neckcompleted161
2026-02-03P3Immunovant Sciences GmbH IMVTNCT05524571 Study to Assess Batoclimab in Participants With Active Thyroid Eye DiseaseThyroid Eye Diseasecompleted86
2026-02-03P2Novartis Pharmaceuticals NVSNCT05592990 A Study to Investigate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles in Patients With Achilles TendinopathyAchilles Tendinopathycompleted45
2026-02-03P1/P2Ocugen OCGNNCT06018558 Study to Assess the Safety and Efficacy of OCU410 for Geographic AtrophyGeographic Atrophyactive not recruiting60
2026-02-03P3CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.NCT06235086 A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes MellitusType 2 Diabetes Mellituscompleted632
2026-02-03P1/P2Boehringer IngelheimNCT06515002 A Study to Test How Well BI 3720931 is Tolerated and Whether it Improves Lung Function in People With Cystic Fibrosis (Lenticlair™ 1)Cystic Fibrosisterminated5
2026-02-04P3Merck Sharp & Dohme LLC MRKNCT04736706 A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination WitCarcinoma, Renal Cellactive not recruiting1688
2026-02-04P3Anthos Therapeutics, Inc.NCT05171049 A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTEVenous Thromboembolism; Deep Venous Thrombosis; Pulmonary Embolismterminated1150
2026-02-04P2Janssen Research & Development, LLCNCT05250973 A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) AmyloidosisAmyloidosisactive not recruiting151
2026-02-04P3AbbVie ABBVNCT05411198 Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years oOpen-Angle Glaucomacompleted74
2026-02-04P3Merck Sharp & Dohme LLC MRKNCT05899049 A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination WitCarcinoma, Renal Cellactive not recruiting251
2026-02-04P2AstraZeneca AZNNCT06529419 A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of ExacerbationsAsthmacompleted537
2026-02-05P3Pfizer PFENCT05583526 A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) TranquilloStable Nonsegmental Vitiligo; Active Nonsegmental Vitiligocompleted607
2026-02-05P2/P3AbbVie ABBVNCT06547125 A Study to Assess Adverse Events and Effectiveness of Intradermally Injected JUVÉDERM® VOLITE™ Gel Filler in Adult Participants For the Improvement of Skin QualSkin Quality Deficitcompleted135
2026-02-05P3Daewoong Pharmaceutical Co. LTD.NCT06671392 A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With HypertensionEssential Hypertensioncompleted198
2026-02-06P3Forma Therapeutics, Inc.NCT04624659 A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)Sickle Cell Diseaseactive not recruiting450
2026-02-06P3Janssen Research & Development, LLCNCT05754957 A Study of Milvexian in Participants After a Recent Acute Coronary SyndromeAcute Coronary Syndromecompleted14194
2026-02-06P1/P2Innate Pharma IPHANCT06088654 Phase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin LymphomaNon Hodgkin Lymphomaterminated23
2026-02-06P3UCB Biopharma SRLNCT06624228 A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic ArthritisPsoriatic Arthritiscompleted553
2026-02-06 est.P2Therakos LLCNCT06646016 EPIC- Extracorporeal Photopheresis (ECP) for Immune-related ColitisImmune-related Colitiswithdrawn
2026-02-06 est.P2Shanghai Auzone Biological Technology Co., Ltd.NCT06757504 Evaluate the Efficacy and Safety of TTYP01 Tablets in Adolescents and Children With ASDAutism Spectrum Disorder (ASD)recruiting150
2026-02-07 est.P3Gan & Lee Pharmaceuticals.NCT06767748 A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal InsulinDiabetesactive not recruiting620
2026-02-08P1/P2Nanjing Immunophage Biotech Co., LtdNCT05142592 Phase1/2a Study for IPG7236 in Patients With Advanced Solid TumorsSafety Issues; Tolerability; Pharmacokineticscompleted34
2026-02-09P2Rhythm Pharmaceuticals, Inc. RYTMNCT06046443 A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic ObesityHypothalamic Obesitycompleted28
2026-02-09P2Pfizer PFENCT06531538 A Study to Learn About How a New Pneumococcal Vaccine Works in ChildrenPneumococcal Diseasecompleted225
2026-02-09P2Chengdu Diao Jiuhong Pharmaceutical FactoryNCT06822946 Zhibitai Capsules for the Treatment of Primary HyperlipidemiaPrimary Hyperlipidemiacompleted201
2026-02-09P2Chengdu Kanghong Pharmaceutical Group Co., Ltd.NCT07101120 A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Adult Participents With Major Depressive DisorderMajor Depressive Disorder (MDD)completed126
2026-02-10P3PTC Therapeutics PTCNCT01247207 Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD)Duchenne Muscular Dystrophyterminated265
2026-02-10P2Sanofi SNYNCT05588843 Dose-finding Study of SAR443122 in Adult Participants With Ulcerative ColitisColitis Ulcerativeactive not recruiting187
2026-02-10P2Intercept PharmaceuticalsNCT05639543 FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) StudyAlcohol Associated Hepatitisterminated67
2026-02-10 est.P2Eagle Pharmaceuticals, Inc. EXPNCT05776004 Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial PneumoniaPneumonia, Bacterialactive not recruiting276
2026-02-10P2Biogen BIIBNCT05798520 A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing ForRelapsing Forms of Multiple Sclerosiscompleted127
2026-02-10 est.P2Guangzhou JOYO Pharma Co., LtdNCT06158490 A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic DermatitisModerate-to-severe Atopic Dermatitisenrolling by invitation120
2026-02-10P2AstraZeneca AZNNCT06299826 A Phase IIb Study of AZD5462 in Patients With Chronic Heart FailureChronic Heart Failurecompleted375
2026-02-10P3Intellia Therapeutics NTLANCT06634420 HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)Hereditary Angioedemaactive not recruiting80
2026-02-11P1/P2Xintela ABNCT05549609 A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg UlcersVenous Leg Ulcercompleted6
2026-02-11P2medac GmbHNCT06075706 Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host DiseaseSteroid-refractory Acute Graft-versus-host Diseaseactive not recruiting49
2026-02-11P3Keymed Biosciences Co.LtdNCT06424470 Study on the Treatment of Prurigo Nodularis With Stapokibart InjectionPrurigo Nodulariscompleted200
2026-02-11P3Amryt PharmaNCT06502990 Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised LipodystrophyGeneralized Lipodystrophyterminated1
2026-02-11P2Astellas Pharma Global Development, Inc.NCT06812754 A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through MenopauseHot Flashescompleted150
2026-02-11P2Pancap Pharma Inc.NCT06949735 Clinical Trial on Digestive Enzymes: Effects on Post-Meal Response to High-Macronutrient MealsGastrointestinal Digestion; Healthy; Gastrointestinal Wellbeing; Gastrointestinal Supplementscompleted24
2026-02-12P3Viridian Therapeutics, Inc. VRDNNCT06625411 An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)Thyroid Eye Diseaseactive not recruiting132
2026-02-12P2Insmed Incorporated INSMNCT06685835 A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)Hidradenitis Suppurativaterminated214
2026-02-12P2Haisco Pharmaceutical Group Co., Ltd.NCT06764862 Evaluating the Efficacy and Safety of of HSK44459 in People With Idiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosiscompleted186
2026-02-12P2Sanofi SNYNCT06790121 A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe AtopicDermatitis Atopiccompleted150
2026-02-12P3Taisho Pharmaceutical IndonesiaNCT07475663 Counterpain PXM Versus Diclofenac Versus PiroxicamAnkle Sprain; Back Pain; Osteoarthritis (OA) of the Knee; Tennis Elbow; Runner's Kneecompleted180
2026-02-13P1/P2ShireNCT01887938 An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic LeukodystrophyMetachromatic Leukodystrophy (MLD)completed24
2026-02-13P3Biohaven Pharmaceuticals, Inc. BHVNNCT04708834 Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive DisorderObsessive Compulsive Disorderterminated772
2026-02-13P3Boston Scientific Corporation BSXNCT05016245 MANDARIN (S6371)Inoperable Hepatocellular Carcinomacompleted92
2026-02-13P3Epion TherapeuticsNCT06100952 Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With KeratoconusKeratoconuscompleted398
2026-02-13P2Corcept Therapeutics CORTNCT06108219 A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)Nonalcoholic Steatohepatitis (NASH); Metabolic Dysfunction-associated Steatohepatitis (MASH)completed175
2026-02-13P3Kodiak Sciences Inc KODNCT06270836 A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)Diabetic Retinopathycompleted255
2026-02-13 est.P2Tonghua Dongbao Pharmaceutical Co.,LtdNCT07036601 Phase II Study of THDBH120 Injection in Overweight or Obese SubjectsOverweight or Obeserecruiting276
2026-02-14 est.P2Convalife (Shanghai) Co., Ltd.NCT06519110 Neratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 MutationsAdvanced Solid Tumorunknown60
2026-02-15P3Beijing Suncadia Pharmaceuticals Co., LtdNCT06825416 A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee ArthroplastyPrevention of Arterial and Venous Thrombosiscompleted1165
2026-02-15P2NeuroTherapia, Inc.NCT07058688 A Study of NTRX-07 in Participants With Alzheimer's DiseaseAlzheimer Disease; Mild Cognitive Impairmentcompleted48
2026-02-15 est.P1/P2Urmila DIwekarNCT07148999 An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for ProveraInfertility (IVF Patients)recruiting200
2026-02-16P3Bristol-Myers Squibb BMYNCT03661320 A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With NivolumabUrinary Bladder Neoplasms; Muscle-Invasive Bladder Cancercompleted855
2026-02-16P3Astellas Pharma Global Development, Inc.NCT05621616 A Study to Learn How Effective and Safe the Drug 'Mirabegron' is and How Long it Stays in the Body of Children Aged 6 Months to Less Than 3 Years of Age With NeNeurogenic Detrusor Overactivitycompleted7
2026-02-16P3RDC Clinical Pty LtdNCT06444763 Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy PopulationChronic Inflammation; Mobility; Muscle Pain; Joint Paincompleted97
2026-02-16P3Good Molecules, LLCNCT07136766 An 18-week Study to Evaluate a Test Product With a Marketed Prescription ProductHyperpigmentationcompleted49
2026-02-16P2Traws Pharma, Inc. TRAWNCT07157007 Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19COVID - 19completed93
2026-02-17P2ITB-Med LLCNCT04803058 A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PERSPECTIVE)Kidney Transplantationterminated7
2026-02-17P2Novartis Pharmaceuticals NVSNCT06293365 Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled SSjögrens Disease; Systemic Lupus Erythematosus; Rheumatoid Arthritisactive not recruiting155
2026-02-18P3Pfizer PFENCT04821622 Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCProstate Canceractive not recruiting599
2026-02-18P2Aviceda Therapeutics, Inc.NCT05839041 A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)Geographic Atrophy of the Macula; Macular Degenerationcompleted300
2026-02-18P3CelltrionNCT06630559 A Study to Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe PsoriasisPlaque Psoriasisactive not recruiting153
2026-02-19P3Kamada, Ltd. KMDANCT04204252 Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"Alpha 1-Antitrypsin Deficiencyterminated98
2026-02-19P2MacroGenics MGNXNCT05848011 A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate CancerAndrogen-Independent Prostatic Cancer; Androgen-Independent Prostatic Neoplasms; Prostate Cancer Reccompleted154
2026-02-19P2Immorna Biotherapeutics, Inc.NCT06581575 A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster VaccineHerpes Zoster (HZ); Infectious Diseases; Shinglesactive not recruiting467
2026-02-20P1/P2Astellas Pharma Global Development, Inc.NCT03288545 A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial CancerCarcinoma, Transitional Cell; Urinary Bladder Neoplasms; Urologic Neoplasms; Renal Pelvis Neoplasms;terminated348
2026-02-20P2Iovance Biotherapeutics, Inc. IOVANCT03645928 Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid TumorsMetastatic Melanoma; Squamous Cell Carcinoma of the Head and Neck; Non-small Cell Lung Cancerterminated225
2026-02-20P3Karyopharm Therapeutics Inc KPTIQNCT04562389 Study of Selinexor in Combination With Ruxolitinib in MyelofibrosisMyelofibrosisactive not recruiting353
2026-02-20P2Mirum Pharmaceuticals, Inc. MIRMNCT04663308 A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)Primary Sclerosing Cholangitisactive not recruiting182
2026-02-20P1/P2ICM Biotech Australia Pty Ltd.NCT04875754 A Study Evaluating the Safety, Tolerability, and Range of Biologically Active Doses of ICM-203 in Mild to Moderate Knee OsteoarthritisOsteoarthritis, Kneecompleted12
2026-02-20P3Novartis Pharmaceuticals NVSNCT05648968 A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic AnemiaWarm Autoimmune Hemolytic Anemia (wAIHA)active not recruiting90
2026-02-20P3mAbxience Research S.L.NCT06596772 A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [Proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid ArthritiRheumatoid Arthritis (RA)completed501
2026-02-20 est.P1/P2Neurodawn Pharmaceutical Co., Ltd.NCT07166380 RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric InfarctionTranscranial Bone Marrow Injection; RK-4; Acute Large Hemispheric Infarction; Acute Ischemic Strokenot yet recruiting18
2026-02-23P2Bristol-Myers Squibb BMYNCT02719613 Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating ElotuzumabMultiple Myelomacompleted67
2026-02-23 est.P3AkesoNCT04974398 A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal CarcinomaNasopharyngeal Carcinomaactive not recruiting296
2026-02-23P3AstraZeneca AZNNCT05301842 Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCCHepatocellular Carcinomaactive not recruiting760
2026-02-23P2Janssen Research & Development, LLCNCT05811351 A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related MacGeographic Atrophycompleted305
2026-02-23P2Regeneron Pharmaceuticals REGNNCT05831176 A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Eosinophilic Gastritis (EoG); Eosinophilic Duodenitis (EoD); Eosinophilic Gastrointestinal Disease (active not recruiting22
2026-02-23P2Qlaris Bio, Inc.NCT06030193 Study of an Investigational Product, QLS-111, Provided as an Eyedrop, for Treatment of Normal Tension Glaucoma (NTG)Normal Tension Glaucoma (NTG); Low-Tension Glaucoma, Bilateral; Low-Tension Glaucoma, Unspecified Eycompleted37
2026-02-23P2Sanofi SNYNCT06102005 Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe AsthmaAsthmacompleted685
2026-02-23P2NovoCure GmbH NVCRNCT06558799 LUNAR-4: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC)Non-Small Cell Lung Cancer (NSCLC)terminated31
2026-02-23P2Avalo Therapeutics, Inc. AVTXNCT06603077 A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis SuppurativaHidradenitis Suppurativacompleted253
2026-02-23P2Suven Life Sciences LimitedNCT06836063 Study to Evaluate Efficacy and Safety of Ropanicant in MDD PatientsMajor Depressive Disorder (MDD)completed214
2026-02-24P3Bausch Health Americas, Inc.NCT05297448 Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With CirrhosisHepatic Encephalopathycompleted517
2026-02-24P3Novartis Pharmaceuticals NVSNCT05380453 Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical RemissionGiant Cell Arteritiscompleted151
2026-02-24P3Incyte Corporation INCYNCT06113445 A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)NonSegmental Vitiligoactive not recruiting467
2026-02-24P3Intra-Cellular Therapies, Inc.NCT06462586 Study of Lumateperone in the Acute Treatment of Patients With Bipolar ManiaBipolar Disorder, Maniccompleted354
2026-02-24P3Haisco Pharmaceutical Group Co., Ltd.NCT07186426 A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic SurgeryPostoperative Pain Managementcompleted405
2026-02-25P3Zambon SpANCT04039347 Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3)Bronchiolitis Obliterans; Obliterative Bronchiolitis; Bronchiolitis Obliterans Syndrometerminated164
2026-02-25 est.P2Beijing InnoCare Pharma Tech Co., Ltd.NCT04711148 A Phase 2 Study of Orelabrutinib in Patients With Relapsing-Remitting Multiple SclerosisRelapsing Remitting Multiple Sclerosisunknown160
2026-02-25P1/P2Quell Therapeutics LimitedNCT05234190 Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant PatientsRejection; Transplant, Liver; Liver Failure; Liver Diseasesactive not recruiting33
2026-02-25P1/P2Amgen AMGNNCT05975073 A Phase 1/2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid TumorsMTAP-null Non-Small-Cell Lung Cancer; MTAP-null Solid Tumorscompleted53
2026-02-25P2Novartis Pharmaceuticals NVSNCT05996835 Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI)Acute Kidney Injury Due to Sepsiscompleted316
2026-02-26P3Pfizer PFENCT05020236 A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other TreatmentsMultiple Myelomarecruiting893
2026-02-26P3AstraZeneca AZNNCT05742802 Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).Chronic Obstructive Pulmonary Disease (COPD)completed1713
2026-02-26P1/P2Resurge Therapeutics Inc.NCT07264205 RT-310 Safety and Feasibility BPH StudyBPH (Benign Prostatic Hyperplasia)active not recruiting20
2026-02-26P1/P2Sinovac Life Sciences Co., Ltd.NCT07543198 Clinical Trial of PCV24 in Adults Aged ≥18 YearsPneumococcal Infectious Diseasecompleted385
2026-02-27P1/P2Sanofi Pasteur, a Sanofi Company SNYNCT06134648 Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine CandidateRespiratory Syncytial Virus Infection; Healthy Volunteers; Human Metapneumoviruscompleted646
2026-02-27P2IpsenNCT06341712 Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With OsteosarcomaOsteosarcoma; Osteosarcoma in Children; Osteosarcoma in Adolescents and Young Adultsterminated10
2026-02-27P2Gan and Lee Pharmaceuticals, USANCT06737042 Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight ParticipantsObesity and Overweightcompleted326
2026-02-27P3Colgate Palmolive CLNCT07263698 Investigation of Clinical Efficacy of a New Mouthwash on Reducing Dental Plaque and Helping Prevent Gum Problems as Compared to a Control MouthwashGingivitis; Plaque, Dentalcompleted80
2026-02-28P2ExCellThera inc.NCT04103879 US Study of UM171-Expanded CB in Patients With High Risk Leukemia/MyelodysplasiaHigh Risk Hematological Malignancy; Cord Blood Transplantcompleted30
2026-02-28 est.P1/P2PT. Prodia Stem Cell IndonesiaNCT05261750 Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal CancerNasopharyngeal Canceractive not recruiting15
2026-02-28P2Shanghai Henlius BiotechNCT05468489 To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLCExtensive Stage Small Cell Lung Canceractive not recruiting200
2026-02-28 est.P2Curacle Co., Ltd.NCT05907330 Phase 2 Study of CU104 in Moderate-Severe Ulcerative ColitisUlcerative Colitisunknown45
2026-02-28 est.P2InSilico Medicine Hong Kong LimitedNCT05975983 Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosis (IPF)recruiting40
2026-02-28 est.P1/P2RemeGen Co., Ltd.NCT06038396 A Study of RC118 Plus Toripalimab / RC148 in Patients with Locally Advanced Unresectable or Metastatic Solid TumorsAdvanced Solid Tumorunknown48
2026-02-28 est.P1/P2Keymed Biosciences Co.LtdNCT06126237 A Study of CM313 in Subjects With Relapsed or Refractory Multiple MyelomaMultiple Myelomaunknown120
2026-02-28 est.P2Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT06592625 Neoadjuvant SHR-A1811 Plus Adebrelimab in HR Negative/Low & HER2 Low Breast Cancer PatientsUntreated Early-stage or Locally Advanced Breast Cancerunknown60
2026-02-28 est.P2Guangzhou JOYO Pharma Co., LtdNCT06697535 A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)Neuromyelitis Optica Spectrum Disordersrecruiting35
2026-02-28P3Sarfez Pharmaceuticals, Inc.NCT07046975 Bioavailability and Bioequivalence Study of Extended Release Torsemide and SpironolactoneBioavailability Heathy Volunteerscompleted24
2026-02-28 est.P2WestVac Biopharma Co., Ltd.NCT07170800 A Phase 2b Clinical Study of JDB0131 Benzenesulfonate TabletsTuberculosis; Multidrug Resistant Pulmonary Tuberculosis; Rifampicin-resistant Tuberculosisrecruiting60
2026-02-28 est.P1/P2Onconic Therapeutics Inc.NCT07364422 To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric CancerGastric Cancer (GC)not yet recruiting49

← 2026-01 | 2026-03 →

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.